Non-Opioid IV Therapy Available for Managing Moderate to Severe Pain
The treatment is approved for the management of moderate to severe pain, alone or in combination with non-nonsteroidal anti-inflammatory drugs in adult patients.
The treatment is approved for the management of moderate to severe pain, alone or in combination with non-nonsteroidal anti-inflammatory drugs in adult patients.
The Food and Drug Administration has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs in patients with coronavirus disease 2019.
Many patients take over-the-counter (OTC) products with potentially serious interactions with the direct-acting oral anticoagulant apixaban.
There was no indication that any particular type of antidepressant was associated with a greater risk.
Older nonsteroidal anti-inflammatory drugs that selectively inhibit cyclooxygenase-2 enzyme, like etodolac and diclofenac, upped stroke mortality.